Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Levocetirizine
Cat. No.:
OB0225LY-0106
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and HPLC.
Size:
Product Overview
Description:
Levocetirizine is the active enantiomer of Cetirizine, which has similar anti-allergic effects but usually fewer side effects.
Synonym:
130018-77-8; (R)-Cetirizine; (-)-Cetirizine; Acetic acid, (2-(4-((R)-(4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-; Acetic acid, 2-[2-[4-[(R)-(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]-; Levocetirizine (dihydrochloride) 2-[2-[4-[(R)-(4-chlorophenyl)-phenylmethyl]-1-piperazinyl]ethoxy]acetic acid
CAS No.:
130018-77-8
Compound CID:
1549000
Formula:
C21H25ClN2O3
Formula Weight:
388.89
Specification
Relative Density:
1.12 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Levocetirizine can be used in drug development e.g. for seasonal and perennial allergic rhinitis and urticaria.
Library Information
Targets:
Histamine receptor family
Receptors:
H1 receptor
Pathways:
Immunology/Inflammation; Neuronal signaling; GPCR/G protein
Plate Number:
AOCL-2
Plate Location:
c9
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
22.5 mg/mL; 57.86 mM
